Anne Andersson
Impact in
- Oncology top 5%
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 18
- Cancer Risks and Factors 8
- HER2/EGFR in Cancer Research 6
- Global Cancer Incidence and Screening 2
-
- Breast Cancer Treatment Studies 9
- Co-authors
- Gunilla Enblad (4 shared papers)Björn Tavelin (4 shared papers)Beatrice Malmer (2 shared papers)Anita Gustavsson (2 shared papers)Malin Sund (4 shared papers)Ulf Näslund (2 shared papers)Oskar Hemmingsson (3 shared papers)Helena Anna Taflin (1 shared paper)
In The Last Decade
Anne Andersson
34 papers receiving 1.3k citations
Anne Andersson's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 493
- Cancer Research 287
- Pathology and Forensic Medicine 128
- Pulmonary and Respiratory Medicine 173
- Endocrinology, Diabetes and Metabolism 81
Countries citing papers authored by Anne Andersson
This map shows the geographic impact of Anne Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Andersson more than expected).
Fields of papers citing papers by Anne Andersson
This network shows the impact of papers produced by Anne Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Andersson. The network helps show where Anne Andersson may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study Hit paper breakdown → | 2021 | 275 |
| 2 | 2014 | 97 | |
| 3 | 2014 | 96 | |
| 4 | 2013 | 80 | |
| 5 | 2013 | 77 | |
| 6 | 2015 | 76 | |
| 7 | 2012 | 65 | |
| 8 | 2014 | 64 | |
| 9 | 2012 | 63 | |
| 10 | 2014 | 63 | |
| 11 | 2013 | 58 | |
| 12 | 2021 | 49 | |
| 13 | 2014 | 45 | |
| 14 | 2013 | 44 | |
| 15 | 2022 | 32 | |
| 16 | 2008 | 29 | |
| 17 | 2015 | 25 | |
| 18 | 2020 | 19 | |
| 19 | 2008 | 14 | |
| 20 | 2023 | 10 |
About Anne Andersson
Anne Andersson is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer Risks and Factors (8 papers), HER2/EGFR in Cancer Research (6 papers), Multiple and Secondary Primary Cancers (3 papers), Global Cancer Incidence and Screening (2 papers), Digital Radiography and Breast Imaging (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Oncology (493 citations), Cancer Research (287 citations), Pathology and Forensic Medicine (128 citations), Pulmonary and Respiratory Medicine (173 citations) and Endocrinology, Diabetes and Metabolism (81 citations). Anne Andersson has collaborated with scholars based in Sweden, Spain and France. Frequent co-authors include Gunilla Enblad, Björn Tavelin, Beatrice Malmer, Anita Gustavsson, Malin Sund, Ulf Näslund, Oskar Hemmingsson, Helena Anna Taflin, Alan A. Arslan and Yelena Afanasyeva. Their work appears in journals such as International Journal of Cancer, Annals of Oncology, BMJ Open, Breast Cancer Research and Treatment and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.